Neuromuscular Translational Research Conference 2022

The annual Neuromuscular Translational Research Conference took place on the 26th-27th April 2022, returning for its 15th year. We were delighted to continue our partnership with the MRC (Medical Research Council), Centre for Genomic Medicine in Neuromuscular Diseases and UCL to host this event which was held online.

MDUK Chair, Prof Mike Hanna and MDUK’s Director of Research, Dr Kate Adcock spoke at the event. Attracting over 300 basic scientists and clinical scientists involved in neuromuscular disease research, the event promotes and shares cutting edge clinical and scientific advances in the neuromuscular field, and encourages new research and collaborations. It showcases a mix of guest lectures with Q&A, research posters, and flash presentations from early career scientists.

There was a wide range of interesting and informative talks from senior researchers from across the world such as:

  • Professor John Svaren, Director of the IDD Models Core at the University of Wisconsin-Madison, who spoke about the challenges and opportunities for clinical trials in Charcot-Marie-Tooth Disease.
  • Dr Elin Haf Davies, CEO of Aparito, who told the audience about smart technologies and how they can be utilised to measure patient reported outcomes and assess activities remotely.
  • Dr Sharif Tabebordbar, from Kate Therapeutics, spoke about how taking advantage of certain biological aspects of adeno-associated viruses (AAV) can be used to develop gene therapies that can be targeted to specific tissues. We are currently funding a project that is examining delivery methods for gene therapy, you can find out more here.

The conference also included several ‘flash’ presentations.  Over 100 delegates submitted posters (brief summaries of a piece of scientific work) in advance that attendees could review online. The highest quality posters were selected to be presented live to the audience. These included work from Karen Wong (Newcastle University) who spoke of how levels of mobility can impact on how people with neuromuscular conditions participate in research studies and Dr Pedro Tomaselli, from the University of São Paulo, who gave an update on the Brazilian participants with neuromuscular conditions who are enrolled in the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGMND).

We will share a link to these presentations as soon as it is available but would like to thank our sponsors for their support of this event*.

*Please note that our sponsors do not have an input or content of this event.

Our Sponsors Logo's